APOE rs439401: Understanding This Genetic Variant
The rs439401 variant is a genetic marker located near the APOE gene, which plays a central role in lipid metabolism. Research has investigated its potential regulatory effects and its association with various health-related traits.
What each genotype means
Typical lipid metabolism profile
This genotype is associated with standard processing of lipids and cholesterol in the body. Research indicates that individuals with this genetic profile generally maintain baseline levels of cardiovascular risk markers compared to those with the T allele.
This genotype is common globally, though exact frequencies vary significantly by ancestral background.
Intermediate lipid metabolism profile
Carriers of this genotype may show intermediate levels of certain lipid markers. Studies have observed that this genetic variation can influence how the body manages triglycerides and waist circumference, though these effects are often subtle and influenced by lifestyle factors.
This heterozygous genotype is frequently observed across diverse global populations.
Altered lipid metabolism profile
Research has associated this specific genotype with higher levels of triglycerides and increased waist circumference in some study populations. These findings suggest a potential influence on metabolic health, though individual outcomes are heavily dependent on diet, exercise, and other genetic factors.
This genotype is present in a significant portion of the global population, with prevalence rates differing by geographic and ancestral origin.
What is rs439401 and Where is it Located?
The rs439401 variant is a single nucleotide polymorphism (SNP) situated in the human genome. Specifically, it is located approximately 1,801 base pairs downstream of the APOE gene on chromosome 19. Because of its proximity to this critical gene, researchers often study rs439401 to determine if it exerts a regulatory influence on how the APOE gene functions. In genetic terms, it is classified as a UTR (untranslated region) variant, meaning it sits in a portion of the DNA that does not code for a protein but may still influence gene expression or stability. Understanding its precise location is essential for scientists mapping the complex landscape of the APOE locus, which is known for its high degree of genetic variation and its significant impact on human health.
The Role of the APOE Gene
The APOE gene provides instructions for making a protein called apolipoprotein E. This protein is a major component of lipoproteins, which are particles that carry fats, including cholesterol, through the bloodstream. By binding to specific receptors on the surface of cells, apolipoprotein E helps clear these fats from the blood, playing a vital role in lipid metabolism. Because of its function, the APOE gene is heavily studied in the context of cardiovascular health and neurological conditions. Variations within or near this gene can influence the efficiency of lipid transport and the overall balance of cholesterol in the body. While rs439401 is not part of the APOE coding sequence itself, its location suggests it may be involved in the complex regulatory network that controls how much apolipoprotein E is produced or how the gene is expressed in different tissues.
Research Associations and Evidence
Scientific research has explored the association between rs439401 and various health traits, particularly those related to lipid metabolism and disease risk. Some studies have examined whether this variant, when inherited alongside specific APOE haplotypes, might influence the risk of conditions like Alzheimer's disease or cardiovascular issues. However, the evidence is nuanced. For instance, some analyses have shown that the association of rs439401 with disease risk can vary depending on the statistical methods used to filter and account for the broader APOE genetic background. Because the APOE region is highly complex, distinguishing the specific effect of a single SNP like rs439401 from the effects of neighboring variants is a significant challenge. Current findings suggest that while there is a potential regulatory link, the clinical impact of this specific variant remains a subject of ongoing investigation rather than a definitive diagnostic marker.
Population Frequency
The frequency of the rs439401 variant varies significantly across different global populations, reflecting the diverse genetic history of human groups. Research indicates that the prevalence of the C allele at this position is approximately 36.8% in European populations, 15.3% in African populations, and 58.6% in East Asian populations. These differences highlight that genetic variants are not distributed uniformly, and what is common in one ancestral group may be rare in another. Such variations are important for researchers to consider when conducting large-scale genetic studies, as they ensure that findings are representative of the global population. Understanding these frequency patterns helps scientists better interpret the potential significance of the variant in different genetic contexts.
What You Can Do With This Information
Information about genetic variants like rs439401 is primarily intended for educational and research purposes. It is important to recognize that a single SNP rarely determines health outcomes on its own; rather, health is the result of a complex interplay between genetics, lifestyle, and environment. If you have received information about your own genetic profile, it is best to view it as a piece of a much larger puzzle. You cannot use this information to diagnose yourself or predict specific health outcomes. If you have concerns about your cardiovascular health, lipid levels, or family history, the most effective step is to consult with a qualified healthcare provider. They can interpret your overall health profile, including clinical blood tests and family history, to provide personalized guidance that is far more accurate than any single genetic variant analysis.
How common is this variant?
The rs439401 variant shows significant global diversity, with frequencies of the C allele ranging from approximately 15% in African populations to nearly 60% in East Asian populations.
Frequently asked questions
Is rs439401 a diagnostic test for heart disease?
No, rs439401 is not a diagnostic test. It is a genetic variant that has been studied for its potential association with lipid metabolism, but it does not determine whether an individual will develop heart disease.
Does having the C allele mean I have high cholesterol?
Not necessarily. Genetic variants are only one factor in lipid metabolism. Cholesterol levels are influenced by a combination of genetics, diet, exercise, and other lifestyle factors.
Should I change my diet based on my rs439401 genotype?
You should not make dietary changes based solely on a single genetic variant. Always consult with a doctor or a registered dietitian to create a nutrition plan that is appropriate for your overall health and clinical blood work.
Where can I find more information about my APOE status?
If you are interested in your APOE status for clinical reasons, speak with your primary care physician or a genetic counselor. They can order appropriate clinical testing if it is medically indicated for your situation.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs439401?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in APOE
Variant in the APOE/TOMM40 locus associated with late-onset Alzheimer's disease risk.
Downstream variant in the APOE region associated with lipid metabolism profiles and healthspan indicators.
Variant (c.497G>A, p.Arg166Gln) in the APOE gene known as Apolipoprotein E4 Christchurch, which has been shown in clinical case studies to confer resistance to familial Alzheimer's disease pathology.
Upstream regulatory variant influencing APOE transcription and plasma lipid modulation.
Defines the APOE ε2 allele, associated with lower LDL cholesterol and reduced risk of Alzheimer's disease.
Regulatory variant in the APOE promoter region modulating transcriptional activity and risk for late-onset neurodegeneration.